Check the spelling or try searching for a more general term.
This interview with Dr. Latina, the inventor of SLT, addresses the role of SLT in clinical practice, including its role as a primary therapy – and as an adjunct to MIGS.
Professor Erica Fletcher, PhD, Leader of the Fundamental Research Program in the Laser for Early AMD (LEAD) clinical trial, explains how the 2RT® unique mechanism of action may remove the early signs of age-related macular degeneration. Professor Fletcher highlights the distinctive differences that set 2RT® apart from current conventional retinal lasers.
Professor Robyn Guymer AM, MBBS, PhD, FRANZCO, FAAHMS, the Principal Investigator for the Laser for Early AMD (LEAD) clinical trial, shares promising results for the implementation of 2RT® to prevent AMD progression. Professor Guymer highlights the importance of the world-first study in determining the role of 2RT® in the AMD treatment paradigm.
Glaucoma, Retinal Disease, Floaters (Vitreous Opacities), Diagnostic Ultrasound
This CRST article features an article by Paul I. Singh, MD, which discusses the first-line benefits of SLT in lowering IOP, reduce medication use, and provide key diagnostic information.
Published in JAMA Ophthalmology, this trial by Chirag P. Shah, MD and Jeffrey S. Heler, MD evaluates the efficacy of YAG laser vitreolysis vs. sham vitreolysis for symptomatic Weiss ring floaters from posterior vitreous detachment, featuring the proprietary Reflex Technology platform.
In this article, Karl Stonecipher, MD (USA) provides his treatment pearls for LFT in clinical practice.
“The Evolving View of Laser Vitreolysis” In this roundtable discussion, ophthalmologists working in glaucoma, retina, cataract and refractive surgery talked with Inder Paul Singh, MD, about prospective clinical study data, hands-on experiences, and how their profession’s view of LFT is evolving alongside growing data and the introduction of the new Reflex Technology platform.
This article discusses the role of ABiC, which has grown into a procedure that is effective, safe and easily combined with other MIGS interventions. Contributing authors include Mahmoud Khaimi, MD (USA), Norbert Koerber, MD, PhD (Germany), Mark Gallardo, MD (USA), Sev Teymoorian, MD (USA) and Leon Au, MD (UK).
The March 2018 issue of CRST featured a case study by Dr. David Lubeck in which ABiC was successfully performed in a patient post-SLT and iStent – speaking to the versatility of iTrack in clinical practice.
Featuring Dr. Mahmoud Khaimi, this CRST article features a case study on the synergies of ABiC and SLT – and the benefits of performing these two procedures in combination.
This whitepaper presents the preliminary 12-month results for ABiC, based on a 228-eye case series by Mahmoud A. Khaimi, MD and Mark J. Gallardo, MD.
Featuring Ike K. Ahmed, MD, this panel discussion on microinvasive glaucoma surgery (MIGS) addresses the collective wisdom and experiences of a leading panel of MIGS experts.
In this article ABiC pioneer Mahmoud A. Khaimi, MD addresses his experience with ABiC, contrasting it against the other MIGS procedures available.
Written by Haiyan Hong, MD, PhD, this whitepaper discusses the complexity of the aqueous outflow system and the importance of understanding of how circulation is regulated, in order to facilitate successful management of glaucoma – and the role of Canaloplasty in addressing all aspects of the outflow mechanism.
At the Inaugural European Laser Innovations Forum in Nice, Prof. John Marshall discussed the evolution of 2RT Retinal Rejuvenation Therapy as an intervention for AMD in its early stages – and how 2RT technology compares to other laser-based retinal treatments.
Ellex sat down with Prof. Andrea Cusumano at the inaugural European Laser Innovations Forum in Nice to discuss the role of 2RT in clinical practice.
Visit our online resource to learn more about how SLT and MIGS are helping to shift the paradigm towards proactive glaucoma care.
Read about the role of MIGS, including iTrack, in the glaucoma treatment algorithm. Blog curated by Mark J. Gallardo, MD (USA).
A simple three-step procedure, learn how ABiC™ can reduce the elevated intraocular pressure associated with glaucoma.
In this video interview, glaucoma expert Mahmoud A. Khaimi, MD (USA), describes the advent of ABiC™ performed with the iTrack™ surgical system.
Read about how SLT can help in the management of modern-day glaucoma. Blog curated by Dr. Savak “Sev” Teymoorian, MD, MBA (USA).
A restorative approach, learn how SLT can restore the eye’s natural drainage channel.
Review more than 200 SLT references, including peer-review papers, articles, posters and book chapters.
Iqbal Ike K. Ahmed, MD, FRCSC, asks a group of experts to address the misconceptions and barriers to adoption for ab interno canaloplasty (ABiC).
Iqbal Ike K. Ahmed, MD, FRCSC, asks this roundtable of surgeons to clarify the misconceptions surrounding selective laser trabeculoplasty (SLT).
Iqbal Ike K. Ahmed, MD, FRCSC, opens up discussion on preferred minimally invasive glaucoma surgery (MIGS) procedures.
The benefits of True Coaxial Illumination, TCI™ extend beyond the safe treatment of floaters. TCI™ can help to prevent the notoriously common patient complaint of sudden floater development after capsulotomy.
David Lubeck, MD discusses the role of ABiC in conjunction with SLT and MIGS.
Watch the iTrack™ as it circumnavigates Schlemm’s, separating the herniations of the meshwork into the collector channels and breaking inner lumen adhesions.
In this supplement to Retina Today, Chirag P. Shah, MD, MPH addresses his pivotal trial into the safety and efficacy of laser vitreolysis.
In this video Mahmoud A. Khaimi, MD (USA) demonstrates restoration of the natural outflow pathway with ABiC™.
The deterioration of transport processes across Bruch’s membrane has been implicated in development of age-related macular degeneration (AMD). This whitepaper by John Marshall, PhD, FRCPath FMedSci, addresses the potential of Ellex 2RT to improve Bruch’s membrane function and delay the development of the disease.
A simple in-office procedure, LFT can help to alleviate the visual disturbance caused by floaters.
Read about how LFT can help in the management of symptomatic floater patients. Blog curated by Paul I. Singh, MD (USA)
Featured in Glaucoma Today, this roundtable discusses the benefits of iTrack™ in targeting multiple sources of outflow resistance.
Read a whitepaper addressing the dual role of SLT as both a diagnostic aid and as a highly effective first-line treatment option.
Read a whitepaper about the transformative role of Reflex technology™ for anterior and posterior YAG treatments.
Dr. Paul Singh (USA) demonstrates the benefits of True Coaxial Illumination, TCI™ enables him to visualize a weiss ring floater and to deliver the energy needed to break down the floater safely.
Dr. Paul Singh (USA) demonstrates the use of titratable illumination to view floaters that are within the posterior capsule clearly – whilst also viewing the retina.
Reflex Technology™ incorporates a proprietary slit lamp illumination tower design, which converges the operator’s vision, the target illumination, and the treatment beam along the same optical path and onto the same optical plane. The illumination tower can be used coaxially to enhance the view of the target opacity and more effectively vaporize it.
In this video, Paul I. Singh, MD (USA) uses the Ultra Q Reflex™ laser to perform Laser Floater Treatment in a patient with a multi-focal lens.
According to iTrack™ expert Mark J. Gallardo, MD (USA), proper visualization of the nasal drainage angle is crucial to the success of ABiC™.
According to Dr. Khaimi, ABiC can be performed in three easy steps.
In this unedited video of ABiC™ in a phakic patient with primary open-angle glaucoma. Dr. Mark J. Gallardo (USA) demonstrated the steps of goniotomy, 360° cannulation and viscodilation of Schlemm’s canal with the iTrack™ surgical system.
This video interview Karl Brasse, MD, MRCOphth (Germany) addresses how Ellex's refined YAG laser technology can secure greater precision in capsulotomy treatment.
In this video interview, Paul I. Singh, MD (USA) addresses the clinical impact of floaters and the success of Laser Floater Treatment in his practice.
In this video interview, refractive specialist Karl G. Stonecipher, MD (USA) addresses his decision to incorporate Laser Floater Treatment into clinical practice.
Compared with its early clinical use in the 1980s, modern laser vitreolysis provides more efficient and safer energy profiles, offering reliable and repeatable outcomes that provide a low rate of complications combined with a high degree of patient satisfaction.
In comparing the preliminary data for ABiC against the published data for the various MIGS devices, ABiC appears to be comparable, if not more effective, than other MIGS procedures.
According to Mark J. Gallardo, MD (USA) ABiC™ has worked so well to control his patients’ IOP and to reduce their medication load that it has become his “go-to” procedure for glaucoma patients requiring surgical intervention.
In the past, vitrectomy has been commonly considered the gold standard for the treatment of debilitating floater symptoms, but the risk of complications means that it may not be suitable for all patients.
This whitepaper highlights the role of SLT across the glaucoma disease process, including its utility as a first-line treatment option.
Beyond nutritional supplements, there’s no intervention that can be made that can affect the course of AMD – only in late diseases,when vision has been impaired. Read an article by Australian retinal specialist Wilson Heriot, MD, PhD, which addresses the role of 2RT Retinal Rejuvenation in the early stages of AMD.
Whether patients with symptomatic floaters should be offered treatment or told to “carry on regardless” continues to be debated. Read the whitepaper to learn more.
Glaucoma specialist Howard Barnebey, MD (USA), provides insight regarding the safety and efficacy of Canaloplasty. Having performed nearly 1000 procedures, Dr. Barnebey uses Canaloplasty across the entire glaucoma spectrum.
The glaucoma medications used to control the IOP of refractive patients often add to the blurred vision experienced by these patients on a daily basis. This leaves the refractive surgeon with the frustrating task of correcting refractive error without being able to eliminate a key contributor to the problem.
Video Interview with Andrew G. Iwach, MD (USA) addresses the demonstrated efficacy of SLT as a primary therapy.
SLT works by stimulating a natural healing response in the body to manage the elevated IOP associated with glaucoma, promoting cellular regeneration without the burn and scar tissue associated with other laser procedures.
Even in an era of highly advanced OCT imaging, ultrasound remains one of the most fundamental diagnostic tools in ophthalmology. Watch the video interview with ultrasound expert Yale Fisher, MD (USA).
Watch the video with Andrzej Dmitriew, MD (Poland) to learn how detection of disorders like posterior vitreous detachment (PVD) in opaque ocular media is easily achieved with B-Scan ultrasound.
When performing SLT on patients with narrow angles, visibility is reduced compared to normal angles. Watch the video to learn more.
When performing SLT on patients with narrow angles, visibility is reduced compared to normal angles. It is important to ensure the patient looks toward the mirror in order to improve visibility.
It is important to note that less energy is required when performing SLT on patients with a heavily pigmented trabeculum. In this case video, extensive mini-bubble formation is noted at the commencement of SLT treatment, indicating that the energy level is too high.
The fully integrated laser-slit lamp design of the IntegrePro™ channels the laser directly through the slit lamp optics, ensuring optimal illumination of the fundus, whilst the motorized safety filter ensures an accurate, color-balanced view. Watch the video to learn more.
In this video, treatment is applied to the retinal periphery. A fast exposure time aided by a precise micromanipulator allows for quick, easy and precise placement over the entire periphery.
Hundreds of spot are placed in the retina to reduce the risk of vitreous hemorrhage and retinal detachment. Watch the video to learn more.
When performing SLT on eyes with irregular pigmentation, always ensure that focus is maintained on the target tissue, and not on the laser beam spot.